A detailed history of Allworth Financial LP transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Allworth Financial LP holds 620 shares of CDMO stock, worth $7,737. This represents 0.0% of its overall portfolio holdings.

Number of Shares
620
Previous 620 -0.0%
Holding current value
$7,737
Previous $7,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

BUY
$6.34 - $9.28 $1,046 - $1,531
165 Added 36.26%
620 $4,000
Q4 2023

Jan 24, 2024

BUY
$4.64 - $9.56 $1,976 - $4,072
426 Added 1468.97%
455 $2,000
Q2 2023

Jul 18, 2023

SELL
$12.96 - $20.93 $803 - $1,297
-62 Reduced 68.13%
29 $0
Q1 2023

Apr 18, 2023

BUY
$13.48 - $18.79 $835 - $1,164
62 Added 213.79%
91 $1,000
Q3 2022

Oct 18, 2022

SELL
$15.33 - $20.36 $10,516 - $13,966
-686 Reduced 95.94%
29 $1,000
Q4 2021

Jan 21, 2022

BUY
$20.7 - $34.18 $600 - $991
29 Added 4.23%
715 $21,000
Q1 2018

May 02, 2018

BUY
$2.32 - $4.22 $1,591 - $2,894
686 New
686 $2,000

Others Institutions Holding CDMO

About Avid Bioservices, Inc.


  • Ticker CDMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,167,500
  • Market Cap $776M
  • Description
  • Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...
More about CDMO
Track This Portfolio

Track Allworth Financial LP Portfolio

Follow Allworth Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Allworth Financial LP with notifications on news.